The FDA has granted accelerated approval to Modeyso (dordaviprone) for the treatment of diffuse midline glioma harboring an ...

Treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy are under review.

The FDA has approved Ajovy (fremanezumab) for the prevention of episodic migraine in pediatric patients aged 6 to 17 years weighing at least 45kg.

Having a supratherapeutic INR while taking warfarin does not significantly increase the risk for brain bleeding after blunt head trauma in older adults.

Exposure to childhood physical or verbal abuse is similarly associated with lower mental well-being during adulthood.

Cognitive functional therapy, with or without biofeedback, is more effective than usual care for treating patients with chronic disabling low back pain.

For older adults with type 2 diabetes, GLP-1 RA use is associated with nonarteritic anterior ischemic optic neuropathy.

The prevalence of disorders of the gut-brain interaction (DGBI) increased from before to after the COVID-19 pandemic.

Central precocious puberty was associated with elevated risk for psychiatric disorders including depression, ADHD, and anxiety.

Influenza-associated acute necrotizing encephalopathy (ANE) in children is associated with high morbidity and mortality.

Transvenous diaphragm neurostimulation was associated with successful weaning in patients with difficulty weaning from mechanical ventilation.

The FDA announced it will now be requiring updated safety labels for all opioid pain medications to better highlight the risks.